Clinical Trials Logo

Clinical Trial Summary

The study is aimed at assessing IGF-1R-Abs in patients with Graves' disease, with or without GO, compared with healthy subjects and patients with autoimmune thyroiditis in a cross-sectional investigation.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT03498417
Study type Observational
Source University of Pisa
Status Completed
Start date June 20, 2018
Completion date July 20, 2018

See also
  Status Clinical Trial Phase
Completed NCT02973802 - ATX-GD-59 in Patients With Graves Disease Not Treated With Anti-thyroid Therapy Phase 1
Active, not recruiting NCT02491567 - DNA Methylation and Autoimmune Thyroid Diseases N/A
Terminated NCT01320813 - Trial Comparing Complication Rates Associated With Robot-assisted Thyroidectomy to External Thyroidectomy N/A
Completed NCT00432146 - Effect of Lugol's Solution in the Patients With Graves' Disease N/A
Completed NCT01727973 - Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy Phase 1/Phase 2
Completed NCT03009357 - Clinical Application of Pulse Rate-monitoring Activity Trackers in Thyrotoxicosis
Recruiting NCT03303053 - Efficacy and Safety of Cholestyramine and Prednisolone as Adjunctive Therapy in Treatment of Overt Hyperthyroidism Phase 3
Completed NCT00782366 - Predictive Genetic Risk Assessment Trial N/A
Recruiting NCT03066076 - Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy Phase 3
Completed NCT02376088 - Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease N/A
Completed NCT01227499 - Differential Diagnosis of STA-PSV in Thyrotoxicosis N/A
Recruiting NCT02203682 - Doxycycline Treatment in Mild Graves' Orbitopathy Phase 2
Completed NCT02993302 - Effects Of Oral Alfacalcidol On Maturation Of Dendritic Cells In Graves' Disease Patients Phase 2
Completed NCT00677469 - Low Doses of Cholestyramine in the Treatment of Hyperthyroidism N/A
Completed NCT00796913 - Remission Induction and Sustenance in Graves' Disease 2 N/A
Completed NCT00150137 - Antithyroid Drugs During Radioiodine Therapy Phase 4
Completed NCT03667157 - Liver Function After Intravenous Methylprednisolone Administration Phase 4
Completed NCT03590080 - Impact of Intravenous Methylprednisolone Treatment on Blood Pressure
Completed NCT01560299 - Evaluation of Optimal Time of Methimazole Discontinuation Before Radio-iodine Therapy in Hyperthyroid Grave's Patients N/A
Completed NCT01039818 - Comparison of Different Doses of 131I in Severe Graves' Hyperthyroidism Phase 3